Pub. Date : 2019 Nov
PMID : 30958073
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Recently, enasidenib and ivosidenib, oral inhibitors of mutated IDH2 and IDH1 genes, respectively, were approved for use in relapsed or refractory acute myeloid leukemia. | enasidenib | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |